VTv Therapeutics : Announces Paul Sekhri as new President and Chief Executive Officer - Form 8-K

July 27, 2022 - vTv Therapeutics Inc. , a clinical stage biopharmaceutical company focused on the development of orally administered treatments for type 1 diabetes , today announced that Paul Sekhri...

Related Keywords

Robert Flamm ,Paul Sekhri ,Cerimon Pharmaceuticals ,Investments Ai Holding ,Burns Mcclellan Inc ,Drug Administration ,Compugen ,Nasdaq ,Tv Therapeutics Inc ,Teva Pharmaceutical Industries Ltd ,Corporate Development ,Ariad Pharmaceuticals ,Lycera Corp ,Chief Executive ,Chief Executive Officer ,Interim Chief Executive Officer ,Executive Vice President ,Breakthrough Therapy ,Novartis Pharma ,Veeva Systems ,Spring Discovery ,Inducement Award Agreement ,Annual Report ,